Batri-7 Attenuates Established Inflammation-Associated Colorectal Adenoma via PI3K/AKT Inhibition and BAX-Associated Apoptosis.
Preclinical findings demonstrate that BT-7 exerts therapeutic efficacy against established inflammation-associated colorectal adenoma, providing a mechanistic foundation for its further translational investigation.